Medical Aesthetic Devices: Technologies and Global Markets

Report Highlights

The global market for medical aesthetic devices reached $4.4 billion in 2013 and increasing to $4.6 billion in 2014. This market should reach nearly $6.2 billion in 2019, demonstrating a compound annual growth rate (CAGR) of 5.8% from 2014 to 2019.

Report Includes

• An overview of the global markets and technologies for medical aesthetic devices.
• Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
• Coverage of medical devices including:
  • Botulinum neuromodulators for aesthetic applications
  • Breast augmentation devices, including implants and injectable materials
  • Injectable dermal fillers
  • Devices for assisted liposuction using ultrasound, light, or water
  • Externally-applied energy-emitting devices
• Details concerning the regulatory environment for medical devices and drugs in the U.S. and Europe as it strongly effects product availability.
• Profiles of major players in the medical aesthetics industry.

SCOPE OF REPORT

This report details the principles of operation, method of manufacture, regulatory restrictions and current status of the global market for the following medical aesthetic devices:

• Botulinum neuromodulators for aesthetic applications.
• Breast augmentation devices, including implants and injectable materials.
• Injectable dermal fillers. 
• Devices for assisted liposuction using ultrasound, light or water.
• Externally-applied energy-emitting devices for:
• Permanent hair removal.
• Ablative skin resurfacing.
• Non-ablative skin resurfacing.
• Treatment of vascular skin lesions.
• Skin tightening.
• Tattoo removal.
• Acne treatment.
• Treatment of pigmented skin lesions.
• Cellulite reduction.

The global market is also segmented geographically into the following regions:

• U.S.
• Brazil.
• China.
• India.
• Mexico.
• Japan.
• Europe.
• Rest of the World.

Trends in the markets are identified and used in conjunction with past market behavior to forecast future revenues and compounded annual growth rates (CAGRs) in current U.S. dollars from 2014 to 2019.

The regulatory environment for medical devices and drugs in the U.S. and Europe is described in detail, as it exerts a strong effect on the availability of the devices considered in this report. The properties and characteristics of human skin, hair and breasts are discussed insofar as they affect device demand.

ANALYST’S CREDENTIALS

J. Richard Rahn has worked in the medical device industry since 2000 and in the industrial instrumentation industry since 1997. He holds a Ph.D. in optical/ chemical physics. He is the author of several scientific publications and has been awarded more than 12 U.S. patents as well as several foreign patents.